Shengquan and Novozymes in partnership to commercialize cellulosic ethanol
News May 11, 2012
Shengquan Group, a Shandong-based company specializing in furan resin and polymers, and Novozymes, a world leader in bioinnovation, has announced a partnership enabling Shengquan to start commercial-scale production of cellulosic ethanol for solvents in June 2012 using Novozymes’ technology.
“Shengquan is a global first mover in this industry, which is on the verge of materializing right now,” says Poul Ruben Andersen, Vice President for Bioenergy at Novozymes. “Shengquan has profound experience in chemical production and is a leading company in commercializing cellulosic ethanol. Novozymes is proud to join Shengquan in nurturing a green and circular bioeconomy which lessens the dependence on fossil fuel resources.”
Shengquan is a leading producer of furfural using xylose in corncobs, a monomer for resin production in the foundry industry. Using Novozymes enzymes, Shengquan will now convert corncob residues from furfural production into fermentable sugars and then into ethanol for solvents and other purposes. Shengquan’s cost model shows that its current production cost of cellulosic ethanol is cost-competitive with conventional ethanol as the feedstock is a by-product of their current production.
Novozymes is a leading enzymatic solution provider in bioenergy. It partners with leading producers of cellulosic ethanol all over the world to commercialize this new technology.
Biofuels boost the economy and create jobs
A recent study by Bloomberg New Energy Finance estimates that the advanced biofuel industry has the potential to create millions of jobs, economic growth and energy security worldwide.
Looking at China alone, the study shows that using less than 20% of the available agricultural residues China could produce more than 89 billion liters (23 million gallons) of biofuel, replacing 37% of its gasoline consumption by 2030. This would create 2.9 million jobs and reduce CO2 emissions from gasoline-based transportation by 29%. The figures would be even higher if biomass from forestry residues, household waste and energy crops was included.
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018